← Leaderboards
Yi Lin
Mayo Clinic Rochester
$6,996,175
Attributed
$9,467,936
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,467,936 · 6
By mechanism
R01$8,198,463 · 4
P50$737,688 · 1
K22$531,785 · 1
Top collaborators
- Sean S Park6 shared
- Lewis R Roberts6 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Liang Wang$6,312,215
- Manish Kohli$4,072,306
- Sean S Park$1,787,171
- Andrew Lewis Feldman$5,717,562
- Sameer Ashok Parikh$248,460
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmuneDendritic CellsMonocyteTumorImmunotherapyCytotoxicInnovationSignal TransductionT-LymphocyteResponseClinical TrialsMediatingImmune Checkpoint InhibitorAutologous Dendritic CellsPhenotypeCd14 GeneMorbidity - Disease RateLymphomaS LymphomaB-Cell Nonhodgkins LymphomaImmune FunctionImmunityCancer Type
Grant awards (23)
Radiation and dendritic cells to hepatomas to improve immunotherapy response$628,467
R01 · FY2025 · CA
Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinoma$610,890
R01 · FY2025 · CA
Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple Myeloma$280,796
P50 · FY2025 · CA · contact PI
Radiation and dendritic cells to hepatomas to improve immunotherapy response$612,951
R01 · FY2024 · CA
Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinoma$610,890
R01 · FY2024 · CA
Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple Myeloma$266,018
P50 · FY2024 · CA · contact PI
Radiation and dendritic cells to hepatomas to improve immunotherapy response$612,054
R01 · FY2023 · CA
Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple Myeloma$190,874
P50 · FY2023 · CA · contact PI
Radiation and dendritic cells to hepatomas to improve immunotherapy response$632,389
R01 · FY2022 · CA
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma$485,760
R01 · FY2022 · CA · contact PI
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma$713,488
R01 · FY2021 · CA · contact PI
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma$401,153
R01 · FY2020 · CA · contact PI
Monocyte promotion of therapy resistance by immune and non-immune mechanisms$363,713
R01 · FY2020 · CA · contact PI
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma$356,587
R01 · FY2019 · CA · contact PI
Monocyte promotion of therapy resistance by immune and non-immune mechanisms$352,801
R01 · FY2019 · CA · contact PI
Monocyte promotion of therapy resistance by immune and non-immune mechanisms$363,713
R01 · FY2018 · CA · contact PI
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma$180,184
R01 · FY2018 · CA · contact PI
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma$545,997
R01 · FY2017 · CA · contact PI
Monocyte promotion of therapy resistance by immune and non-immune mechanisms$363,713
R01 · FY2017 · CA · contact PI
Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance$146,520
K22 · FY2017 · CA · contact PI
Monocyte promotion of therapy resistance by immune and non-immune mechanisms$363,713
R01 · FY2016 · CA · contact PI
Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance$192,780
K22 · FY2016 · CA · contact PI
Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance$192,485
K22 · FY2015 · CA · contact PI